ERBA VITA

STEROL STOP ADVANCE 30 TABLETS

STEROL STOP ADVANCE 30 TABLETS

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

Sterol Stop ADVANCE

Description
Food supplement with red rice monacolins, coenzyme Q10, folic acid and plant extracts.
With NaringiCol, plant-based naringin extracted from pomelo fruits.
Cassia nomame which promotes the metabolism of triglycerides and cholesterol.
Berberis supports the function of the cardiovascular system.
Olive supports lipid metabolism.
Vitamin E has an antioxidant effect.
Also for vegans.

Ingredients
Berberis (Berberis aristata DC) bark dry extract titrated at 97% in berberine; NaringiCol, 98% naringin from pomelo fruit [Citrus grandis (L.) Osbeck,]; milk thistle [Silybum marianum (L.) Gaertn.] fruit dry extract titrated at 80% in silymarin; bulking agents: cellulose, dibasic calcium phosphate; cassia nomame [Chamaecrista nomame (Sieber) H.Ohashi] leaf dry extract titrated at 8% in total flavonoids, olive (Olea europaea L.) fruit dry extract, titrated at 10% in hydroxytyrosol, total monacolins from fermented red rice from Monascus purpureus, corn starch; anti-caking agents: magnesium salts of fatty acids (vegetable), silicon dioxide; Natural D-alpha tocopheryl acetate (vitamin E), ubidecarenone (coenzyme Q10), pteroylmonoglutamic acid (folic acid).

Gluten free.
Naturally lactose- free

Nutritional characteristics
Quantities per recommended daily dose (1 tablet)
Total monacolins from red rice <3 mg*
Berberis bark dry extract
title in berberine
200 mg
194 mg
Naringicol
of which naringin
150 mg
147 mg
Milk thistle fruit dry extract
silymarin title
150 mg
120 mg
Cassia nomame leaves dry extract
total flavonoid content
100 mg
8 mg
Olive fruit dry extract
hydroxytyrosol title
80 mg
8 mg
Vitamin E 12 mg (100% NRV**)
Coenzyme Q10 5 mg
Folic acid 200 mcg (100% NRV**)
* not less than 2.9 mg per tablet.
**NRV: Daily Nutrient Reference Value.

How to use
It is recommended to take 1 tablet per day with water, preferably in the evening after the main meal.

Warnings
Keep out of reach of children under 3 years of age. Do not exceed the recommended daily dose. Supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle. Do not take during pregnancy or breastfeeding, in children under 18, or in adults over 70. Consult your doctor before use if you have any health problems. Do not take if you are taking cholesterol-lowering medications. Do not take if you are already taking other products containing red yeast rice. It is recommended not to consume more than 3 mg of red yeast rice monacolins per day.

Conservation
Store in a cool, dry place, away from heat sources.

Format
30 tablets of 1 g.
Net weight: 30 g.

Cod. METASTECPR

ERBA VITA

STEROL STOP ADVANCE 30 TABLETS

STEROL STOP ADVANCE 30 TABLETS

MINSAN code: 984499994
EAN Code: 0767787924232
Previous price: €19,38
Regular price €19,38
Regular price €22,90 Sale price €19,38
-15% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.